Intrinsiqq
Telomir Pharmaceuticals Inc. logo

Telomir Pharmaceuticals Inc.

TELO

Compare

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$27M
EPS-$0.90
P/E-0.41
P/FCF–
EV/EBITDA–
FCF Yield–
Div. Yield–
Net Debt/FCF–
Telomir Pharmaceuticals Inc. intrinsic value
52-Week Range
$0.36$1.09

Profitability & Returns

Revenue

N/A

Net Income (TTM)

-$5M

▲ +37.0% YoY

Op. Margin

–

ROIC

–

Cash Flow & Balance Sheet

FCF

N/A

Op. Cash Flow (TTM)

-$5M

▲ +27.3% YoY

Net Debt

-$5M

Net Cash Position

Cash & Equiv.

$5M

Continue Research

Peers

Pharmaceutical Preparations · Pick stocks to compare with TELO

CompareIntrinsic value
ERNAEterna Therapeutics Inc.
$1.36-16.56%20
ROIVRoivant Sciences Ltd
$38.66-0.78%42
FHTXFoghorn Therapeutics Inc.
$1.72-3.37%46
OCULOcular Therapeutix Inc.
$5.57-4.95%10
TNGXTango Therapeutics Inc.
$21.73-4.32%25
PVLAPavella Therapeutics Inc.
$143.21-1.76%40
XERSXeris Biopharma Holdings, Inc.
$16.97+2.11%34
ACADAcadia Pharmaceuticals Inc.
$17.38-1.19%71

Telomir Pharmaceuticals (TELO) in two numbers

Dividend
None
No dividend in the SEC filings we hold.
Dividends
P/E
-0.41
Negative: a loss over the last twelve months.
Financials

Questions about Telomir Pharmaceuticals

Does Telomir Pharmaceuticals (TELO) pay a dividend?

No. Telomir Pharmaceuticals (TELO) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: 10-Q filed 5 Nov 2026 (period ending 30 Sept 2026), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in TELO's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing TELO

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.